Search Results for "fish oil"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for fish oil. Results 11 to 13 of 13 total matches.
See also: Lovaza, Vascepa

Who Should Take Vitamin Supplements?

   
The Medical Letter on Drugs and Therapeutics • Dec 12, 2011  (Issue 1379)
, fish, fish 700-900 mcg (3000 IU) oil, beta carotene in green or yellow or orange fruits ...
Many patients ask their healthcare providers whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamins.
Med Lett Drugs Ther. 2011 Dec 12;53(1379):101-3 |  Show IntroductionHide Introduction

Benzyl Alcohol Lotion for Head Lice

   
The Medical Letter on Drugs and Therapeutics • Jul 27, 2009  (Issue 1317)
% benzyl alcohol; the vehicle is 5% mineral oil. MECHANISM OF ACTION — Lice exposed to benzyl alcohol ...
The FDA has approved benzyl alcohol lotion, 5% (Ulesfia Lotion - Sciele) for treatment of head lice in patients ≥6 months old. The active ingredient is 5% benzyl alcohol; the vehicle is 5% mineral oil.
Med Lett Drugs Ther. 2009 Jul 27;51(1317):57-8 |  Show IntroductionHide Introduction

Addendum: Aducanumab (Aduhelm) for Alzheimer's Disease

   
The Medical Letter on Drugs and Therapeutics • Jul 26, 2021  (Issue 1629)
has proposed to classify as GRASE include oils, lotions, creams, gels, butters, pastes, ointments, and sticks ...
In June 2021, the FDA approved the IV amyloid beta-directed monoclonal antibody aducanumab (Aduhelm) for treatment of Alzheimer’s disease. The approval did not restrict use of the drug to patients with mild cognitive impairment or mild dementia, which was the population enrolled in the clinical trials. Now, Biogen, with the permission of the FDA, has made an addition to the labeling of the drug that says: Treatment with Aduhelm should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical...
Med Lett Drugs Ther. 2021 Jul 26;63(1629):120 |  Show IntroductionHide Introduction